Intelligent Medicine Acquisition Corp. Unit
IQMDU
IQMDU was delisted on the 26th of April, 2023.
13 hedge funds and large institutions have $3.59M invested in Intelligent Medicine Acquisition Corp. Unit in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 8 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
35% less funds holding
Funds holding: 20 → 13 (-7)
88% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 8
100% less capital inflows, than outflows
Capital inflows: $68.4K | Capital outflows: $28.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$14.6K |
| 2 |
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$3.01K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Calamos Advisors
Naperville,
Illinois
|
-$12.6M |
| 2 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
-$8.11M |
| 3 |
CCA
Castle Creek Arbitrage
Avon,
Colorado
|
-$4.04M |
| 4 |
LMR Partners
London,
United Kingdom
|
-$2.03M |
| 5 |
DCM
Difesa Capital Management
New York
|
-$1.01M |
IQMDU Hedge Fund Activity: Q4 2022 in Review
13 of the 6,241 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Unit (IQMDU) for Q4 2022, worth a combined $3.59M — down 89% from $32.4M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of IQMDU and 1 opened new positions — a net loss of 7 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was UBS Group, adding an estimated $14.6K. The largest seller was Calamos Advisors, exiting entirely with an estimated $12.6M sold.
- 13 institutional investors held Intelligent Medicine Acquisition Corp. Unit (IQMDU) as of Q4 2022, down from 20 in Q3 2022.
- Funds reported $3.59M of Intelligent Medicine Acquisition Corp. Unit stock for Q4 2022, down 89% quarter-over-quarter.
- 1 fund opened new Intelligent Medicine Acquisition Corp. Unit positions in Q4 2022 and 8 closed out, a net change of -7 holders.
- The largest Intelligent Medicine Acquisition Corp. Unit buyer in Q4 2022 was UBS Group, an estimated $14.6K added.
- The largest Intelligent Medicine Acquisition Corp. Unit seller in Q4 2022 was Calamos Advisors, an estimated $12.6M sold.
Based on aggregated 13F filings for Q4 2022.